Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Suppression of RNA-DNA hybrids - towards a novel and coherent mechanism governing repetitive DNA stability, aging, and neurodegeneration
EF 2015-16
Résumé
Amyotrophic lateral sclerosis (ALS) is a fatal disease of the brain and spinal cord. Most ALS patients will die within the first 2-5 years after a diagnosis is made, while function and quality of life rapidly deteriorate during intervening years. Approximately 3000 Canadians currently live with this devastating disease, but sadly there is no known cure. Mutations in the gene ATXN2 can cause ALS and a related disease of the brain called spinocerebellar ataxia 2 (SCA2), both of which are characterized by the loss of brain cells called neurons. But why do mutations in ATXN2 lead to the death of neurons? What processes contribute to this pathology and can we stop it? In a breakthrough study on yeast cells, we recently discovered that the ATXN2 gene prevents the formation of DNA-damaging structures called RNA-DNA hybrids. When ATXN2 is missing, these hybrids accumulate in cells causing DNA instability and premature 'aging'. Based on these findings, we hypothesize that mutations in the human ATXN2 gene lead to the accumulation of RNA-DNA hybrids in brain cells over time, which ultimately manifests in lethal DNA damage. Additionally, we suspect that these mutations also cause RNA-DNA hybrid accumulation within our body's stem cells, leading to defects in the birth of new brain cells. In this study, we will test if the ATXN2 gene maintains DNA stability, prevents early aging, and enables stem cells to function normally by preventing RNA-DNA hybrids. Furthermore, we will test if various approaches that suppress RNA-DNA hybrids can return diseased cells to their normal state. Ultimately, our research will reveal how mutations in this gene lead to ALS/SCA2, and will enable us to devise strategies that target abnormal processes contributing to these devastating diseases.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
339602
Name
Abraham Karan J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Suppression of RNA-DNA hybrids - towards a novel and coherent mechanism governing repetitive DNA stability, aging, and neurodegeneration
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Genome Stability; Mechanisms Of Aging; Neurodegeneration
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal disease of the brain and spinal cord. Most ALS patients will die within the first 2-5 years after a diagnosis is made, while function and quality of life rapidly deteriorate during intervening years. Approximately 3000 Canadians currently live with this devastating disease, but sadly there is no known cure. Mutations in the gene ATXN2 can cause ALS and a related disease of the brain called spinocerebellar ataxia 2 (SCA2), both of which are characterized by the loss of brain cells called neurons. But why do mutations in ATXN2 lead to the death of neurons? What processes contribute to this pathology and can we stop it? In a breakthrough study on yeast cells, we recently discovered that the ATXN2 gene prevents the formation of DNA-damaging structures called RNA-DNA hybrids. When ATXN2 is missing, these hybrids accumulate in cells causing DNA instability and premature 'aging'. Based on these findings, we hypothesize that mutations in the human ATXN2 gene lead to the accumulation of RNA-DNA hybrids in brain cells over time, which ultimately manifests in lethal DNA damage. Additionally, we suspect that these mutations also cause RNA-DNA hybrid accumulation within our body's stem cells, leading to defects in the birth of new brain cells. In this study, we will test if the ATXN2 gene maintains DNA stability, prevents early aging, and enables stem cells to function normally by preventing RNA-DNA hybrids. Furthermore, we will test if various approaches that suppress RNA-DNA hybrids can return diseased cells to their normal state. Ultimately, our research will reveal how mutations in this gene lead to ALS/SCA2, and will enable us to devise strategies that target abnormal processes contributing to these devastating diseases.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Abraham, Karan J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~